News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$AVRW .05 +53.85% It's well known that Sera Labs Health NUTRI-STRIPS are the more effective alternative to traditional supplements. Sales are starting to build up. Supply and Demand. #OTCQB https://seralabshealth.com/collections/nutri-strips
$AVRW #OTCQB .041 Thin to .06 http://seralabshealth.com You can follow Sera Labs on Facebook and Instagram at @seratopical, as well as on X (Twitter) at @Sera_Labs
10K 24 days past due - Another delisting coming?
Halt - Delisting - Bankruptcy
https://fintel.io/sfs/us/avrw#10-K
https://www.avenirwellness.com/sec-filings
Buying continues to come into AVRW to kick off a new week. The stock pps is responding nicely with a walking up getting underway, as we can see with a move into the .05 level already. Investors are seeing how oversold this stock is right now and accumulating in anticipation of the very positive sales growth year projected for 2024.
$AVRW .0499 +17.55% New Blog! "Seratopical Revolution vs Naked & Thriving: Similarities, Differences & How To Choose The Best Products For You" https://seralabshealth.com/blogs/blog/seratopical-revolution-vs-naked-thriving-similarities-differences-how-to-choose-the-best-products-for-you
@SeralabsHealth @AvenirWellness #OTCQB
THE 10K IS OUT - NOPE JUST KIDDING - BAD JOKE, JUST LIKE THE COMPANY
3 Weeks now past the due date. Imagine that. It takes a lot of work to fabricate some
numbers that won't be too far fetched to be called out by the SEC and will keep the
current shareholder's from fleeing in droves before the delisting and then the ultimate
BANKRUPTCY.
https://fintel.io/sfs/us/avrw#10-K
https://www.avenirwellness.com/sec-filings
Go AVRW$$!
POTENTIAL BUYER BEWARE - READ THE POSTS
AND DEFINITELY LOOK AT THE DAILY VOLUMES.
THE TECHNICAL'S COULD LOOK GOOD ON PAPER
BUT OVERALL - THIS BARELY EVEN TRADES BECAUSE
IT IS ABOUT TO BE FLUSHED DOWN THE TOILET.
No "Investor" would buy this POS right now.
The whopping 3640 shares traded today were either from those already
gambling here - or new gambler's. This is NOT an "investor's" stock.
This is a HUGE gamble. They can't even file on time. They know little
to NOTHING about the markets and basically were reverse merged into
Cure Pharmaceutical by way of the Chairman of the Board making a
HUGE mistake with IONIC and the debt (which is in DEFAULT) and then
of course (working with an offshore company) to buy back some patents
and the manufacturing facility.... and leaving Nancy Duitch/shareholder's
holding a big bag of shit along with the DEFAULTED debt and subsequent
lawsuit
I don't know how ANYONE could think ANY of this is going to turn out to be a
spectacular 2024 for the company which is on LIFE SUPPORT from the CEO's
credit card.
BANKRUPTCY or MIRACLE - I'm saying BANKRUPTCY.
Another gain for AVRW today with a close at the high point. Investors are seeing that this stock is set up to reward us in 2024 as the company executes on all if ts plans for market share growth with the increasingly popular Seratopical skin care brand.
Avenir Wellness Solutions, Inc. (OTC: AVRW)
$0.0425 +$0.0025 (+6.13%)
At close: 4:00:00 PM ET, 04/19/2024
Previous close $0.0400
Today's open $0.0400
Today's volume 3.6K
Today's range $0.0400 $0.0425
Avenir Wellness Name Change - ND, LLC
This company isn't even close to being an "officially traded company" anymore. It will probably become Nancy Duitch LLC after the bankruptcy and it can't be traded anymore. When a company can't issue more shares - or - even get a loan through a financial institution and has to depend upon the founder's credit card
...
Oh well - BANKRUPTCY or MIRACLE.
The Agreement provides for a secured loan facility of up to $250,000, of which the Company borrowed an initial amount of $39,000 (the “Initial Principal Amount”) on January 4, 2024. The Agreement provides for the ability of the Company to request additional loan amounts up to $211,000 (the “Future Advances”), inclusive of the outstanding balances of certain credit cards (the “Cards”) used exclusively by the Company of which are issued in the name of the Executive.
More nice action on AVRW today with all trades on the high/ask prices.
Investors seeing this stock has lots for upside potential and accumulating.
Avenir Wellness Soluutions, Inc. (OTC: AVRW)
Recent Trades - All 7 today ...
Time ET Ex Price Change Volume
14:50:34 Q 0.04 0.008 10,000
13:48:13 Q 0.0399 0.0079 24,900
13:47:47 Q 0.03595 0.00395 100
13:42:00 Q 0.0398 0.0078 16,445
13:41:33 Q 0.0397 0.0077 8,455
13:41:32 Q 0.0397 0.0077 100
13:41:32 Q 0.0359 0.0039 100
$AVRW Skincare Product, Seratopical Solutions' "Harmony Toner", is Now Available on the Seratopical Website!
Great video with Facial Plastic Surgeon Dr. Michael Persky
Link: https://seralabshealth.com/products/
#sales #revenues
You "FORGOT" this official news - DEBT
The company has so much debt, they can't get any credit, like a healthy
company does. This Line of Credit is probably gone by this point at approx.
$40K per month burn rate. A company being run off the CEO's credit card.
On January 4, 2024, Avenir Wellness Solutions, Inc. (the “Company”) and Nancy Duitch, the Chief Executive Officer of the Company (the “Executive”), entered into that certain Senior Secured Promissory Note and Security Agreement (the “Agreement”).
The Agreement provides for a secured loan facility of up to $250,000, of which the Company borrowed an initial amount of $39,000 (the “Initial Principal Amount”) on January 4, 2024. The Agreement provides for the ability of the Company to request additional loan amounts up to $211,000 (the “Future Advances”), inclusive of the outstanding balances of certain credit cards (the “Cards”) used exclusively by the Company of which are issued in the name of the Executive. The portion of the principal amount of the Agreement (the “Principal Amount”) comprised of the Initial Principal Amount and the Future Advances (and excluding the outstanding balances on the Cards), accrues interest at an annual rate of 12%, or 18% in the event of default. The Principal Amount plus all accrued and unpaid interest is due and payable in full on the sooner of: (i) the demand of the Holder; and (ii) March 31, 2024. The Company may prepay the Principal Amount, in whole or in part, without the prior written consent of the Executive and without penalty. The Company granted the Executive a security interest in all of the Company’s present and future personal property.
In the event of default, the Executive may, upon written notice to the Company, declare the Principal Amount, including any accrued interest, immediately due and payable in cash and in full. The following constitutes events of default: (i) the Company fails to pay when due any principal or interest payment on the due date, and such payment has not been made within ten (10) days of the Company’s receipt of the Executive’s written notice to the Company of such failure to pay; (ii) the Company materially breaches any other covenant contained in the Agreement and such failure continues for fifteen (15) days after the Company receives written notice of such material breach from the Executive; (iii) the Company voluntarily files for bankruptcy protection or makes a general assignment for the benefit of creditors; or (iv) the Company is the subject of an involuntary bankruptcy petition and such petition is not dismissed within sixty (60) days.
https://app.quotemedia.com/data/downloadFiling?webmasterId=102691&ref=317982190&type=HTML&symbol=AVRW&cdn=a1ea3d8a58c485a9a9312963fb53c353&companyName=Avenir+Wellness+Solutions+Inc&formType=8-K&formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&dateFiled=2024-01-12
A successful 2024 for AVRW is just what all the official news from the company has detailed is coming together now. While we await the 2023 year end 10K filing and also more updates on progress, it's good to review the most recent information which has so far been provided this year:
Avenir Wellness Solutions Issues 2024 Marketing Growth Plans to Shareholders for Seratopical Revolution Skin Care Line with Support from Nicole Kidman and Facial Plastic Surgeon Dr. Michael Persky
New TikTok Shop Ready for Launch to Help Grow Brand Awareness and Product Sales
February 13, 2024 News Link:
https://finance.yahoo.com/news/avenir-wellness-solutions-issues-2024-140000098.html
A OTCQB HALT then back to the Grey market
Which really doesn't matter too much since this
POS barely trades at all anyhow. 100 shares today.
BANKRUPTCY is imminent unless a miracle happens.
THEY ARE WORKING HARD TOWARD BANKRUPTCY
Really hard.
BANKRUPTCY or MIRACLE ??
Oh where oh where has the 10K gone.....
oh where oh where can it be ?
https://www.avenirwellness.com/sec-filings
https://fintel.io/sfs/us/avrw#10-K
Let's see if it makes it before midnight.... maybe they are
up and working their asses off in Brisbane right now to get
the filing done before midnight USA time - who knows......
AS OF RIGHT NOW 8:55pm US time - NADA
POS company, POS management, POS Chairman of the Board
BANKRUPTCY or MIRACLE ????
Looking forward to a successful 2024. Great products, and quality spokespeople. Sounds like the ingredients for a winner.
It's already 9:30pm in Brisbane - I wonder who/where the report
is or isn't being prepared. https://www.timeanddate.com/worldclock/australia/brisbane
10K - to be or not to be - that is the question
So far, it is not to be: https://fintel.io/sfs/us/avrw#10-K
BANKRUPTCY - or - MIRACLE
$AVRW Great Video here: CEO Nancy Duitch and Brand Ambassador Nicole Kidman Discuss their Alliance to Support Wholly-Owned Subsidiary Sera Labs
https://vid.cdn-website.com/ad0e02d3/videos/uJEcyoV4QPmJKpXoSxbh_Untitled-v.mp4
Sounds like something a CEO who is keeping her company alive
off of here own Line of Credit on a "Credit Card" would say to keep
shareholder's updated - it's really quite "fantastical" (fantasy like)
expectations. 🤣
BANKRUPTCY or MIRACLE
$AVRW: Avenir Wellness Solutions has never been in a better position to capitalize on the high intrinsic value of our unique and proprietary skin care formulations. With 15 patents under our control, the highly positive reviews Seratopical DNA Complex is receiving, and more new products in development, 2024 is set up to be a growth year for the Company. We look forward to keeping our shareholders informed of our progress, developments and milestones as we move forward.
Sincerely,
Nancy Duitch, CEO
Feb. 13th News Link:
https://finance.yahoo.com/news/avenir-wellness-solutions-issues-2024-140000098.html
Not sure that will even do any good.
I think she's too far gone already. RD did a job on ND
and hoodwinked her. I still say there had to have been
some "business" between the two before the debacle
happened. Nothing like taking out the 11 Million in debt
from IONIC to buy out a "friends" business so that your
own shitty company shows that there is revenue being
generated. What a shit show it's been.
$AVRW Security Details #OTCQB https://www.otcmarkets.com/stock/AVRW/security
And today a Whopping 75 shares have traded so far.
AVRW Bid: 0.035 Ask: 0.04 Last: 0.0393 Chg ($): 0.00 Vol: 75
The anticipation and the shares FLYING OFF THE SHELVES.
Time will tell - but when a company is being kept open by a
LINE OF CREDIT on the CEO's Credit card - that normally
doesn't translate into good outcomes - especially when they
are over their heads in debt.
BANKRUPTCY or MIRACLE
$AVRW #OTCQB Seratopical Solutions "Harmony Toner" Available on the Seratopical Website! #sales #revenues https://seralabshealth.com/products/ Also available at CVS Retail and AMAZON Stores
Notice the AVRW pps starting to walk higher now in anticipation of the company's 10K report that we should see filed soon. All the official news from AVRW management to date has been very positive and they have clearly projected a strong growth year for 2024. Just a matter of time for higher pps valuations to continue building here.
$AVRW Seratopicals store on Amazon #Revenues #OTCQB
https://www.amazon.com/stores/SERATOPICAL/Homepage/page/473637CB-F4D4-470C-B60D-7B3885CDED6E?lp_slot=auto-sparkle-hsa-tetris&store_ref=SB_A04197472SH5XD3NMXT7L-A08646773CQFBV70N5Y1K&ref_=cm_sw_r_ud_ast_store_C2NDJSDGTZ9HT4QH9A4D #Amazon.com
You hit it exactly, ProfitScout. Another microcap company files for an extension. Must happen two thousand times every quarter. It's no big deal. It will all be corrected in a week or two, just like it almost always is.
This company hardly ever files on time.
They are a complete failure. Profit - they have NEVER turned
a profit in the company's history. NEVER
BANKRUPTCY is imminent without some MIRACLE happening.
|
Followers
|
36
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
3593
|
|
Created
|
11/14/16
|
Type
|
Free
|
| Moderators ProfitScout Dickmo jedijazz greendolphin11 budfoxfun BlazingStocks | |||
Avenir Wellness Solutions (OTC: AVRW)
Formerly CURE Pharmaceutical (OTC: CURR)
For more information, please visit: www.avenirwellness.com and www.seralabshealth.com
COMPANY UPDATE:
Press Release | 02/13/2024
Link: https://feeds.issuerdirect.com/news-release.html?newsid=6554360501139897
Brand New Avenir Wellness DNA Product: https://seralabshealth.com/products/dna-complex
CEO INTERVIEW on Apple Podcasts:
"Lifetime of Health and Wellness - Nancy Duitch, CEO The Sera Labs"
Host April Franzino is joined by:
Nancy Duitch, CEO of The Sera Labs (see image below).
"Nancy discusses how she has spent her entire career working on solution-based health, wellness and beauty products to help people look and feel their absolute best."
Instagram: https://www.instagram.com/beautybizshow/
See omnystudio.com/listener for privacy information.
AVENIR WELLNESS: BUILDING INOVATIVE WELLNESS TECHNOLOGIES FOR THE FUTURE
Avenir Wellness is a vertically integrated drug delivery and development company
Committed to improving drug efficacy, safety, and patient experience through its proprietary drug dosage
Spokesperson Nicole Kidman, Actor (see image below).
Visit the Seratopical Store on AMAZON
LINK: https://www.amazon.com/stores/SERATOPICAL/page/473637CB-F4D4-470C-B60D-7B3885CDED6E?ref_=ast_bln
The plant based, alcohol-free, non-CBD, anti-aging beauty line is available Wednesday, June 9
Sera Labs, a subsidiary of Avenir Wellness Solutions, announced a new ad campaign and launch of Seratopical Revolution, a new clean, plant-based, technologically advanced, anti-aging, ‘revolutionary,’ beauty line.
Nicole Kidman and Sera Labs Inc., an Avenir Wellness Solutions Company, launch Seratopical Revolution. (Photo: Business Wire)
The line touts 11 luxurious products which are all are made in the U.S., available at accessible pricing, and are designed to make you feel more youthful and hydrated from head to toe. Award-winning actress Nicole Kidman, Sera Labs’ strategic business partner and global brand ambassador, collaborated with Sera Labs to design the Loving Hands Essential Oil , Indulgence Brown Sugar Scrub , Harmony Face & Neck Toner , and Gleaming for the ultimate brightening glow. The full line of products can be seen at Seratopicalrevolution.com .
“I really wanted to create something that was meaningful to me and that I knew people would genuinely enjoy,” said Kidman, Seratopical strategic business partner and global brand ambassador. “These products are personal to me from the scent to the texture. I am so excited to share them with the world and hope everyone loves them as much as we do.”
Seratopical Revolution marries nature and science into one clean and nourishing line of beauty products. The line’s P?P complex, developed by CURE Pharmaceutical, drives natural, plant-based ingredients into the deeper layers of the skin by utilizing a proprietary tri-peptide delivery system. Unlike other companies that use alcohol as a delivery system, which is incredibly drying to the skin, Seratopical Revolution’s natural oil and surfactant delivery systems are efficacious and offer almost immediate results.
“It’s been an incredible ride creating this line with Nicole,” said Nancy Duitch , Sera Labs CEO and CURE Pharmaceutical Chief Strategic Officer. “There are a lot of beauty companies, but the problem is that most of them don’t understand that without an effective delivery system, the products are sitting on top of your skin and clogging your pores. Our proprietary formulators have developed a high-tech delivery system which allows the ingredients to go deep into the skin. Our loyal customers will benefit from scientifically backed ingredients that are designed to enhance hydration and rejuvenate collagen. Revolution offers a full-body line packed with natural plant extracts and peptide blends.”
Seratopical Revolution products can be purchased online at seratopicalrevolution.com
Ad campaign photo and product images: https://www.dropbox.com/sh/o8l39o5xb0yj4bs/AAAj1WTWRwK05EpziP4BJn7ka?dl=0
For more information visit: Seratopical.com , Seralabshealth.com and follow us on Instagram at @seratopical , as well as Twitter , and Facebook . Media contact: press@theseralabs.com .
About Sera Labs
Sera Labs® is a trusted leader in the health, wellness, and beauty sectors of innovative products with cutting edge technology and superior ingredients such as CBD and clean plant-based products. Sera Labs creates high quality products that use science-backed, proprietary formulations. Its more than 20 products are sold under the brand names Seratopical ™, SeraLabs™, and Gordon’s Herbals™. Sera Labs sells its products at affordable prices, making them easily accessible on a global scale. Strategically positioned in the growth market categories of beauty, health & wellness. Sera Labs products are sold in major national drug, grocery chains and mass retailers. The company also sells products under private label to major retailers and multi-level marketers, as well as direct-to-consumer (DTC), via online website orders, including opt-in subscriptions. For more information visit: Seratopical.com , Seralabshealth.com and follow us on Instagram at @seratopical , as well as Twitter , and Facebook . Media contact: press@theseralabs.com .
About Avenir Wellness Solutions Company
Avenir Wellness is the pioneering developer of CUREform™, a patented drug delivery platform that offers a number of unique immediate- and controlled-release drug delivery vehicles designed to improve drug efficacy, safety, and patient experience for a wide range of active ingredients. As a vertically integrated company, AVRW’s 25,000 square foot, FDA-registered, NSF® cGMP-certified manufacturing facility enables it to partner with pharmaceutical and wellness companies worldwide for private and white-labeled production. Avenir has partnerships in the U.S., China, Mexico, Canada, Israel, and other markets in Europe.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210609005442/en/
Avenir Wellness [OTC: AVRW] and Canopy Growth to Produce CBD Oral Thin Films
AVRW has an FDA- and DEA- registered, GMP manufacturing facility and is a pioneering developer of CUREform™, a patented drug delivery platform. CUREform™ includes CUREfilm®, one of the most advanced oral thin films on the market today; microCURE™, an innovative emulsion technology utilizing proprietary encapsulation techniques; and CUREpods™ a novel chewable delivery system.
AVRW names Canopy Rivers Chairman John K. Bell, FCA, FCPA, ICD.D to its board of directors. Bell brings more than 40 years of experience to the company, most recently serving as chairman of the Canopy Rivers board of directors and former chairman of Canopy Growth’s board of directors.
AVRW offers combined technologies that provide opportunities for both immediate and controlled-release drug delivery of a wide range of active ingredients. AVRW partners with biotech, pharmaceutical, and wellness companies worldwide and has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector, with partnerships in the U.S.A, Canada, Israel, and other markets. The AVRW company mission is to improve people’s lives by redefining how medicines are delivered and experienced.
AVRW Products Fall Into Two Categories: Nutraceuticals (dietary supplements) and Pharmaceutical Medicines
Nutraceuticals:
CUREfilm® Sleep is a daily dietary supplement that delivers a unique blend of five active ingredients with the CUREfilm® platform to promote healthy sleep patterns. This product is launched in U.S. markets.
CUREfilm® D is a high-potency dietary supplement that provides 50,000 IU of Vitamin D3 delivered with the CUREfilm® platform.
CUREfilm™ Hemp delivers hemp extracts via the CUREfilm® dosage form. This product is launched in U.S. markets.
CUREfilm® β-Caryophyllene is a dietary supplement that contains 30mg of β-Caryophyllene, a powerful terpene known for its anti-inflammatory and analgesic properties.
Pharmaceuticals:
CUREfilm® Blue contains 50mg of Sildenafil delivered with the CUREfilm® platform.
CUREfilm® Canna delivers synthetic and plant-derived cannabinoids in an oral thin film for pharmaceutical indications.
AVRW Expands to Europe, Signs Licensing Agreement with ReLeaf Europe to Provide Advanced Cannabinoid Delivery
On February 5th AVRW announced that it had signed an exclusive licensing agreement with ReLeaf Europe, one of Europe’s leading pharmaceutical groups specialized in medicinal cannabis products. The agreement grants ReLeaf Europe exclusive access to the AVRW encapsulation technology for certain oral and topical cannabis products in the Netherlands, the world’s first medical cannabis market. ReLeaf Europe products will be the first to use the CUREinside™ quality mark to bolster consumer confidence. Europe is one of the world’s largest medical cannabis markets due to various governments’ approval for medicinal purposes.
ReLeaf Europe is one of the few pharmacy providers of pharmaceutical-grade medicinal cannabis oils in Europe and an ideal partner for the AVRW first step into the European market because of its commitment to establishing clinical evidence and following EU GMP and GDP standards. Through this agreement, AVRW will roll out its powered by CURE strategy that includes exclusive licensing relationships to build global market share.
ReLeaf Europe is tackling the largest market in the world for cannabis by establishing a foothold in Holland — a market estimated to reach $2.6B by 2028 — and by pursuing innovative delivery systems and distribution networks. AVRW will power several ReLeaf Europe products, including one sublingual tincture and two topical creams to be launched in 2020.
Major Earnings Potential in the Emerging Medicinal Cannabis Industry
The Cannabis plant has an estimated 113 different compounds, out of which THC and CBD are the two main constituents. THC is mainly responsible for the psychoactive effects or the
feeling of “high” caused by the use of cannabis. CBD on the other hand, has several powerful anti-inflammatory, analgesic, neuroprotective and anti-anxiety properties, which explains its growing popularity to treat a plethora of medical conditions. Unlike THC, CBD does not have any psychotropic effects and hence is widely preferred.
CBD is now being used to treat a wide array of medical conditions such as cancer, cardiovascular anomalies, arthritis, anxiety, depression and Insomnia. In addition, it has also been proven to possess neuroprotective benefits that can treat diseases such as seizures, Multiple Sclerosis (MS), Alzheimer’s, Parkinson’s and Schizophrenia to name a few. There is a growing preference for CBD over traditional pharmaceutical options as these have minimal side effects and are non-addictive.
The global legal marijuana market is likely to reach over USD 66.3 billion by the end of 2025, as per a report by Grand View Research, Inc, growing at a CAGR of 23.9%. There is a growing acceptance of the curative effects of cannabis, with some countries such as Canada and certain states of U.S legalizing the use of Marijuana for medical and recreational use. Research has time and again shown that cannabinoids (CBD), extracted from the cannabis plant, have varied medical uses with minimal side effects, making it a sought-after alternative to traditional pharmaceutical options.
AVRW has signed a licensing and collaboration agreement with
Vanguard Scientific Systems, Inc.
Vanguard is a premier provider of equipment, systems and performance solutions servicing the botanical extraction industry, including the MIDAS XII, a next-generation GMP compliant supercritical CO2 extraction technology, as well as industrially scaled CO2 facility solutions. The license gives Vanguard the right to practice CURE’s patented cannabis extraction methods, providing customer confidence in choosing Vanguard’s portfolio of extraction manufacturers
The industry is poised to grow to $2.1 billion in 2020, a 700% increase from 2016. Those numbers are not only appealing to the players in the CBD market but also serve as an incredible opportunity the pharmaceutical companies to create novel solutions for disease with large unmet medical needs. AVRW is strategically positioned with multiple high value assets and extremely well-placed marketing partners to optimize the company’s earnings potential in the growing fields of key drug supply and delivery solutions, including the multi-billion-dollar CBD marketplace. For more information on Avenir Wellness (OTCQB: AVRW ) visit: http://www.avenirwellness.com
Company News
02/13/2024 Avenir Wellness Solutions Issues 2024 Marketing Growth Plans to Shareholders for Seratopical Revolution Skin Care Line with Support from Nicole Kidman and
Facial Plastic Surgeon Dr. Michael Persky
09/19/2023 Avenir Wellness Solutions Announces Return of Stock Trading Back to OTCQB Market
08/08/2023 Avenir Wellness Solutions Announces New Ticker Symbol As Final Part of Exciting New Brand Identity
05/17/2023 Avenir Wellness Solutions Update to Stockholders
04/28/2023 New to The Street Announces the Televised Lineups for Shows 461, 462, and 463; Airings on Three Networks Will Begin on Saturday, April 29, 2023, at 3:30 PM ET
04/26/2023 Avenir Wellness Solutions (OTCQB:CURR) to Present at the Planet MicroCap Showcase - Live Webcast Available
04/25/2023 Avenir Wellness Letter to Stockholders
04/13/2023 New to The Street Announces the Televised Lineups for Shows 452, 457, and 458, Airings on Three Networks Will Begin Tonight, Thursday, April 13, 2023, at 9:30 PM ET
DISCLAIMER:
Nothing in the contents transmitted on this board should be construed as an investment advisory, nor should it be used to make investment decisions. There is no express or implied solicitation to buy or sell securities. The author(s) may have positions in the stocks or financial relationships with the company or companies discussed and may trade in the stocks mentioned. Readers are advised to conduct their own due diligence prior to considering buying or selling any stock. All information should be considered for information purposes only. No stock exchange has approved or disapproved of the information here.
